C50 Category · further specificity required Malignant neoplasm of breast
ICD-10-CM C50 identifies “Malignant neoplasm of breast” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 2: Neoplasms
Code-level instructions
Includes3
- connective tissue of breast
- Paget's disease of breast
- Paget's disease of nipple
Use additional code1
code to identify estrogen, and other hormones and factors receptor status (Z17.-)
Inherited instructions
Chapters 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
More specific codes
C50.0Malignant neoplasm of nipple and areolaCategory · further specificity requiredC50.1Malignant neoplasm of central portion of breastCategory · further specificity requiredC50.2Malignant neoplasm of upper-inner quadrant of breastCategory · further specificity requiredC50.3Malignant neoplasm of lower-inner quadrant of breastCategory · further specificity requiredC50.4Malignant neoplasm of upper-outer quadrant of breastCategory · further specificity requiredC50.5Malignant neoplasm of lower-outer quadrant of breastCategory · further specificity requiredC50.6Malignant neoplasm of axillary tail of breastCategory · further specificity requiredC50.8Malignant neoplasm of overlapping sites of breastCategory · further specificity requiredC50.9Malignant neoplasm of breast of unspecified siteCategory · further specificity requiredC50.AMalignant inflammatory neoplasm of breastCategory · further specificity requiredOfficial index references
References from other codes (11)
Excludes 1 · malignant neoplasm of connective tissue of breast (C50.-)
Excludes 1 · malignant neoplasm of breast (C50.-)
Excludes 1 · Paget's disease of breast or nipple (C50.-)
Excludes 1 · malignant neoplasm of breast (C50.-)
Code also · malignant neoplasm of breast (C50.-)
Code first · malignant neoplasm of breast (C50.-)
Code first · malignant neoplasm of breast (C50.-)
Code first · malignant neoplasm of breast (C50.-)
Inclusion terms · Conditions classifiable to C50.-
Inclusion terms · Conditions classifiable to C50.-
Code also · conditions classifiable to C50.-
History
Code history
Latest recorded change · FY2025
Effective from
- Code-level rules changed
Malignant neoplasm of breast
Category — select a more specific code
CDC/NCHS · FY2025All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | Code-level rules changed |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.